Publications by authors named "Angela Neubauer"

Claim this Profile
S
Subcutaneous Allergen Immunotherapy With Hypoallergenic Bet v 1 Compared to Conventional Extract: Poorer Blocking Antibody Capacity Dominated by IgG Instead of IgG.
Lorenz Aglas, Line Kring Tannert, Serge A Versteeg, Scott A Smith, Ewa A Bartko, Angela Neubauer

Allergy· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG response.
Julia Eckl-Dorna, Milena Weber, Victoria Stanek, Birgit Linhart, Robin Ristl, Angela Neubauer

EBioMedicine· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rhinovirus Species-Specific Antibodies Differentially Reflect Clinical Outcomes in Health and Asthma.
Spyridon Megremis, Katarzyna Niespodziana, Clarissa Cabauatan, Paraskevi Xepapadaki, Marek L Kowalski, Angela Neubauer

Am J Respir Crit Care Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32.
Verena Niederberger, Angela Neubauer, Philippe Gevaert, Mihaela Zidarn, Margitta Worm

J Allergy Clin Immunol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endolysosomal protease susceptibility of Amb a 1 as a determinant of allergenicity.
Martin Wolf, Lorenz Aglas, Teresa E Twaroch, Markus Steiner, Sara Huber, Angela Neubauer

J Allergy Clin Immunol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope-based grass pollen allergy vaccine with allergen extract-based vaccines.
Milena Weber, Katarzyna Niespodziana, Birgit Linhart, Angela Neubauer, Hans Huber

J Allergy Clin Immunol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epicutaneous allergen application preferentially boosts specific T cell responses in sensitized patients.
Raffaela Campana, Katharina Moritz, Angela Neubauer, Hans Huber, Rainer Henning

Sci Rep· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing Proteolytic Fingerprints of Antigen-Presenting Cells during Allergen Processing.
Heidi Hofer, Tamara Weidinger, Peter Briza, Claudia Asam, Martin Wolf, Angela Neubauer

Int J Mol Sci· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy.
Petra Zieglmayer, Margarete Focke-Tejkl, René Schmutz, Patrick Lemell, René Zieglmayer, Angela Neubauer

EBioMedicine· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent occurrence of T cell-mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments.
Raffaela Campana, Katharina Moritz, Katharina Marth, Angela Neubauer, Hans Huber

J Allergy Clin Immunol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin test evaluation of a novel peptide carrier-based vaccine, BM32, in grass pollen-allergic patients.
Verena Niederberger, Katharina Marth, Julia Eckl-Dorna, Margarete Focke-Tejkl, Milena Weber, Angela Neubauer

J Allergy Clin Immunol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.
Margarete Focke-Tejkl, Milena Weber, Katarzyna Niespodziana, Angela Neubauer, Hans Huber

J Allergy Clin Immunol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy.
Laurian Zuidmeer-Jongejan, Hans Huber, Ines Swoboda, Neil Rigby, Serge A Versteeg, Angela Neubauer

Int Arch Allergy Immunol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular evolution of hypoallergenic hybrid proteins for vaccination against grass pollen allergy.
Birgit Linhart, Margarete Focke-Tejkl, Milena Weber, Meena Narayanan, Angela Neubauer

J Immunol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A general strategy for the generation of hypoallergenic molecules for the immunotherapy of fish allergy.
Ines Swoboda, Nadja Balic, Christoph Klug, Margit Focke, Milena Weber, Angela Neubauer

J Allergy Clin Immunol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies.
Laurian Zuidmeer-Jongejan, Montserrat Fernandez-Rivas, Lars K Poulsen, Angela Neubauer, Juan Asturias

Clin Transl Allergy· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Responsiveness of the major birch allergen Bet v 1 scaffold to the gastric environment: impact on structure and allergenic activity.
Ana I Sancho, Andrea Wangorsch, Bettina M Jensen, Andrew Watson, Yuri Alexeev, Angela Neubauer

Mol Nutr Food Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant allergens: what does the future hold?
Rudolf Valenta, Katarzyna Niespodziana, Margit Focke-Tejkl, Katharina Marth, Hans Huber, Angela Neubauer

J Allergy Clin Immunol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered IgE epitope presentation: A model for hypoallergenic activity revealed for Bet v 1 trimer.
Raffaela Campana, Susanne Vrtala, Bernhard Maderegger, Yuliya Dall'Antonia, Domen Zafred, Angela Neubauer

Mol Immunol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoallergenic derivatives of the major birch pollen allergen Bet v 1 obtained by rational sequence reassembly.
Raffaela Campana, Susanne Vrtala, Bernhard Maderegger, Peter Jertschin, Gottfried Stegfellner, Angela Neubauer

J Allergy Clin Immunol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of recombinant production on the immunologic behavior of birch pollen isoallergens.
Michael Wallner, Martin Himly, Angela Neubauer, Anja Erler, Michael Hauser

PLoS One· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of a functional monomolecular protein lattice consisting of an s-layer fusion protein comprising the variable domain of a camel heavy chain antibody.
Magdalena Pleschberger, Angela Neubauer, Eva M Egelseer, Stefan Weigert, Brigitte Lindner

Bioconjug Chem· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrochemistry of nano-scale bacterial surface protein layers on gold.
Marlene Handrea, Mario Sahre, Angela Neubauer, Uwe B Sleytr, Wolfgang Kautek

Bioelectrochemistry· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis